Literature DB >> 10791585

Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease.

M Mukisi-Mukaza1, A Elbaz, Y Samuel-Leborgne, L Kéclard, C Le Turdu-Chicot, E Christophe-Duchange, G Mérault.   

Abstract

This prospective study examined the prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adult sickle cell disease patients in Guadeloupe. Screening of osteonecrosis of the femoral head was performed using radiography, bone scintigraphy, and tomodensitometry. One hundred thirteen adults with sickle cell disease (67 SS and 46 SC patients) comprised the study population. Forty-two (37.2%) patients had osteonecrosis of one or both hips (67 [29.6%] hips) without association to a particular genotype, although bilateral involvement was more frequent among SS patients. While the prevalence of femoral head osteonecrosis increased with age, patients of all ages were affected, particularly young SC adults. Osteonecrosis of the femoral head was diagnosed at preradiographic stages (stage I) in 30% of hips and was frequently asymptomatic (60% of all cases; 95% and 90% of stages I and II, respectively). Osteonecrosis of the femoral head was significantly associated with a history of leg ulcer and osteonecrosis of the humeral head. SS patients with higher hemoglobin levels had an increased risk of osteonecrosis of the femoral head.

Entities:  

Mesh:

Year:  2000        PMID: 10791585     DOI: 10.3928/0147-7447-20000401-17

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  12 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?

Authors:  Nathalie Lemonne; Yann Lamarre; Marc Romana; Martin Mukisi-Mukaza; Marie-Dominique Hardy-Dessources; Vanessa Tarer; Danielle Mougenel; Xavier Waltz; Benoît Tressières; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Blood       Date:  2013-04-11       Impact factor: 22.113

3.  Pathophysiology and risk factors for osteonecrosis.

Authors:  Kalpit N Shah; Jennifer Racine; Lynne C Jones; Roy K Aaron
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  Characterization of opioid use in sickle cell disease.

Authors:  Jin Han; Jifang Zhou; Santosh L Saraf; Victor R Gordeuk; Gregory S Calip
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-08-16       Impact factor: 2.890

Review 5.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.

Authors:  Michaela A Dinan; Chia-Hung Chou; Bradley G Hammill; Felicia L Graham; Kevin A Schulman; Marilyn J Telen; Shelby D Reed
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

7.  Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  A L Akinyoola; I A Adediran; C M Asaleye; A R Bolarinwa
Journal:  Int Orthop       Date:  2008-07-17       Impact factor: 3.075

8.  Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional study.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Vitor Fortuna
Journal:  Int Orthop       Date:  2018-03-26       Impact factor: 3.075

9.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 10.  Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).

Authors:  Ademola Samson Adewoyin
Journal:  Anemia       Date:  2015-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.